Literature DB >> 12734815

Influence of surfactant molecules as air-entraining agent for bone cement macroporosity.

S Sarda1, M Nilsson, M Balcells, E Fernández.   

Abstract

Calcium phosphate bone cements (CPBCs) represent a potential synthetic alternative to bone-graft materials in bone surgery applications. CPBCs are biocompatible, bioresorbable, and slowly are replaced by new bone in vivo. However, CPBCs do not develop a macroporosity during setting that would allow fast bone ingrowth and good osteointegration of the implant. For this reason, recent research has approached the problem of inducing macroporosity inside the bone cement without influencing its normal setting. In this study, a new method for obtaining injectable macroporous CPBCs is proposed. It is based on the use of sodium dodecyl sulphate (SDS) as an air-entraining agent. The results have shown that the liquid-to-powder ratio and the SDS concentration, as well as the diameter and the interconnectivity of the macropores, can control the micro- and macroporosity. This new technology can be used to develop and optimize new commercial products for osteoporotic bone filling applications. Furthermore, the presented method also can be used at low temperatures before an operation to produce preformed implants to fit the particular needs of a patient. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734815     DOI: 10.1002/jbm.a.10458

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  10 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 2.  Injectable foams for regenerative medicine.

Authors:  Edna M Prieto; Jonathan M Page; Andrew J Harmata; Scott A Guelcher
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-11

Review 3.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

4.  Biomechanical, histological and histomorphometric analyses of calcium phosphate cement compared to PMMA for vertebral augmentation in a validated animal model.

Authors:  Luis Alvarez Galovich; Antonio Perez-Higueras; Jose R Altonaga; José Manuel Gonzalo Orden; Maria Lluisa Mariñoso Barba; Maria Teresa Carrascal Morillo
Journal:  Eur Spine J       Date:  2011-07-20       Impact factor: 3.134

5.  Production of in-situ macropores in an injectable calcium phosphate cement by introduction of cetyltrimethyl ammonium bromide.

Authors:  Xiupeng Wang; Jiandong Ye; Xia Li; Hao Dong
Journal:  J Mater Sci Mater Med       Date:  2008-05-02       Impact factor: 3.896

6.  Creation of macroporous calcium phosphate cements as bone substitutes by using genipin-crosslinked gelatin microspheres.

Authors:  Meng Li; Xingyan Liu; Xudong Liu; Baofeng Ge; Keming Chen
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

7.  Preparation and characterization of calcium phosphate biomaterials.

Authors:  A R Calafiori; G Di Marco; G Martino; M Marotta
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

8.  Bi-layered calcium phosphate cement-based composite scaffold mimicking natural bone structure.

Authors:  Fupo He; Jiandong Ye
Journal:  Sci Technol Adv Mater       Date:  2013-08-16       Impact factor: 8.090

9.  Calcium Phosphate Bone Cements Including Sugar Surfactants: Part One-Porosity, Setting Times and Compressive Strength.

Authors:  Ariane Bercier; Stéphane Gonçalves; Olivier Lignon; Juliette Fitremann
Journal:  Materials (Basel)       Date:  2010-09-30       Impact factor: 3.623

10.  Calcium Phosphate Bone Cements Including Sugar Surfactants: Part Two-Injectability, Adhesive Properties and Biocompatibility.

Authors:  Ariane Bercier; Stéphane Gonçalves; Helène Autefage; Fabienne Briand-Mesange; Olivier Lignon; Juliette Fitremann
Journal:  Materials (Basel)       Date:  2010-12-02       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.